Orthocell Limited (OCC.AX)

AUD 1.25

(-0.4%)

Total Assets Summary of Orthocell Limited

  • Orthocell Limited's latest annual total assets in 2024 was 26.61 Million AUD , down -10.1% from previous year.
  • Orthocell Limited's latest quarterly total assets in 2024 FY was 26.61 Million AUD , down -10.1% from previous quarter.
  • Orthocell Limited reported annual total assets of 29.6 Million AUD in 2023, down -21.88% from previous year.
  • Orthocell Limited reported annual total assets of 37.89 Million AUD in 2022, up 96.04% from previous year.
  • Orthocell Limited reported quarterly total assets of 24.91 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Orthocell Limited reported quarterly total assets of 26.61 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Orthocell Limited (2024 - 2013)

Historical Annual Total Assets of Orthocell Limited (2024 - 2013)

Year Total Assets Total Assets Growth
2024 26.61 Million AUD -10.1%
2023 29.6 Million AUD -21.88%
2022 37.89 Million AUD 96.04%
2021 19.33 Million AUD -16.57%
2020 23.17 Million AUD 70.4%
2019 13.59 Million AUD 160.0%
2018 5.22 Million AUD -26.95%
2017 7.15 Million AUD 0.64%
2016 7.11 Million AUD 8.83%
2015 6.53 Million AUD 27.21%
2014 5.13 Million AUD 191.1%
2013 1.76 Million AUD 0.0%

Peer Total Assets Comparison of Orthocell Limited

Name Total Assets Total Assets Difference
EZZ Life Science Holdings Limited 25.55 Million AUD -4.161%
Anatara Lifesciences Ltd 1.67 Million AUD -1492.369%
Zelira Therapeutics Limited 5.18 Million AUD -413.468%
Biome Australia Limited 8.27 Million AUD -221.564%
Patrys Limited 4.16 Million AUD -539.546%
Imugene Limited 151.39 Million AUD 82.42%
Noxopharm Limited 6.78 Million AUD -292.337%
PYC Therapeutics Limited 91.23 Million AUD 70.829%
Chimeric Therapeutics Limited 15.27 Million AUD -74.261%
Prescient Therapeutics Limited 20.39 Million AUD -30.512%
Proteomics International Laboratories Limited 10.87 Million AUD -144.735%
Cynata Therapeutics Limited 8.38 Million AUD -217.29%
CSL Limited 56.93 Billion AUD 99.953%
Arovella Therapeutics Limited 13.28 Million AUD -100.345%
Bio-Gene Technology Limited 3.15 Million AUD -742.363%
Clinuvel Pharmaceuticals Limited 231.12 Million AUD 88.484%
Starpharma Holdings Limited 36.81 Million AUD 27.704%
Nanollose Limited 241.95 Thousand AUD -10900.248%
Memphasys Limited 12.43 Million AUD -114.118%
Invex Therapeutics Ltd 6.12 Million AUD -334.885%
NeuroScientific Biopharmaceuticals Limited 5.43 Million AUD -389.622%
Amplia Therapeutics Limited 14.84 Million AUD -79.286%
Botanix Pharmaceuticals Limited 112.46 Million AUD 76.335%
Island Pharmaceuticals Limited 2.56 Million AUD -937.844%
Race Oncology Limited 20.22 Million AUD -31.572%
Nyrada Inc. 5.9 Million AUD -350.551%
Telix Pharmaceuticals Limited 398.3 Million AUD 93.318%
Dimerix Limited 32.07 Million AUD 17.031%
PharmAust Limited 11.12 Million AUD -139.241%
Immutep Limited 147.44 Million AUD 81.95%
Clarity Pharmaceuticals Ltd 154.62 Million AUD 82.788%
Alterity Therapeutics Limited 19.22 Million AUD -38.45%
BTC Health Limited 5.14 Million AUD -416.92%
Acrux Limited 8.96 Million AUD -196.945%
Neuren Pharmaceuticals Limited 247.97 Million AUD 89.267%
Biotron Limited 493.47 Thousand AUD -5293.415%
Tissue Repair Ltd 19.38 Million AUD -37.266%
AdAlta Limited 5.57 Million AUD -377.574%
Radiopharm Theranostics Limited 72.03 Million AUD 63.053%
Hexima Limited 2.26 Million AUD -1072.991%
AnteoTech Limited 9.38 Million AUD -183.709%
Paradigm Biopharmaceuticals Limited 27.39 Million AUD 2.83%
Recce Pharmaceuticals Ltd 6.36 Million AUD -317.847%
Avecho Biotechnology Limited 7.31 Million AUD -263.63%
Actinogen Medical Limited 21.31 Million AUD -24.884%
Immuron Limited 15.54 Million AUD -71.159%
Argenica Therapeutics Limited 16.37 Million AUD -62.51%